SNV · As filed with the SEC
Synovus Financial balance sheet, by quarter
The statement as Synovus Financial presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED BALANCE SHEETS · USD thousands
| USD thousands | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 |
|---|---|---|---|---|
| ASSETS | ||||
| Interest-earning deposits with banks and other cash and cash equivalents | 2,239,915 | 2,820,054 | 2,675,110 | 2,977,667 |
| Federal funds sold and securities purchased under resale agreements | 34,292 | 32,262 | 31,123 | 16,320 |
| Total cash, cash equivalents, and restricted cash | 2,274,207 | 2,852,316 | 2,706,233 | 2,993,987 |
| Investment securities held to maturity | 2,450,885 | 2,502,639 | 2,546,741 | 2,581,469 |
| Investment securities available for sale | 7,575,468 | 7,798,824 | 7,840,385 | 7,551,018 |
| Loans held for sale (includes $41,083 and $33,448 measured at fair value, respectively) | 147,811 | 153,037 | 121,669 | 90,111 |
| Loans, net of deferred fees and costs | 43,753,234 | 43,536,716 | 42,648,738 | 42,609,028 |
| Allowance for loan losses | (469,521) | (464,831) | (478,207) | (486,845) |
| Loans, net | 43,283,713 | 43,071,885 | 42,170,531 | 42,122,183 |
| Cash surrender value of bank-owned life insurance | 1,156,297 | 1,150,853 | 1,148,075 | 1,139,988 |
| Premises, equipment, and software, net | 376,013 | 378,739 | 381,925 | 383,724 |
| Goodwill | 480,440 | 480,440 | 480,440 | 480,440 |
| Other intangible assets, net | 26,436 | 29,063 | 31,691 | 34,318 |
| Other assets | 2,713,905 | 2,638,989 | 2,911,431 | 2,856,406 |
| Total assets | 60,485,175 | 61,056,785 | 60,339,121 | 60,233,644 |
| LIABILITIES AND EQUITY | ||||
| Liabilities | ||||
| Deposits: | ||||
| Non-interest-bearing deposits | 11,053,423 | 11,658,129 | 11,543,123 | 11,596,119 |
| Interest-bearing deposits | 38,950,306 | 38,266,878 | 39,299,938 | 39,499,240 |
| Total deposits | 50,003,729 | 49,925,007 | 50,843,061 | 51,095,359 |
| Federal funds purchased, securities sold under repurchase agreements, and other short-term borrowings | 62,467 | 85,327 | 83,002 | 131,728 |
| Long-term debt | 3,008,195 | 3,909,478 | 2,096,918 | 1,733,109 |
| Other liabilities | 1,571,580 | 1,498,331 | 1,903,837 | 2,007,197 |
| Total liabilities | 54,645,971 | 55,418,143 | 54,926,818 | 54,967,393 |
| Equity | ||||
| Shareholders' equity: | ||||
| Preferred stock - no par value; authorized 100,000,000 shares; issued 22,000,000 | 537,145 | 537,145 | 537,145 | 537,145 |
| Common stock - $1.00 par value; authorized 342,857,142 shares; issued 172,734,160 and 172,185,507, respectively; outstanding 138,813,060 and 141,165,908, respectively | 172,734 | 172,703 | 172,660 | 172,186 |
| Additional paid-in capital | 3,999,363 | 3,992,061 | 3,983,395 | 3,986,729 |
| Treasury stock, at cost; 33,921,100 and $31,019,599 shares, respectively | (1,359,096) | (1,359,113) | (1,337,676) | (1,216,827) |
| Accumulated other comprehensive income (loss), net | (676,797) | (739,221) | (826,718) | (970,765) |
| Retained earnings | 3,145,388 | 3,014,111 | 2,861,945 | 2,736,089 |
| Total Synovus Financial Corp. shareholders' equity | 5,818,737 | 5,617,686 | 5,390,751 | 5,244,557 |
| Noncontrolling interest in subsidiary | 20,467 | 20,956 | 21,552 | 21,694 |
| Total equity | 5,839,204 | 5,638,642 | 5,412,303 | 5,266,251 |
| Total liabilities and equity | 60,485,175 | 61,056,785 | 60,339,121 | 60,233,644 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.